Cardiol Therapeutics Inc.

10:23 AM EST - Cardiol Therapeutics Inc. : Announced the filing of a new patent application covering the use of cannabidiol (CBD) to improve the outcome of patients with COVID-19. This new patent application includes the administration of CBD to reduce the severity of disease in COVID-19 patients with pre-existing cardiovascular conditions, and to prevent the progression of such conditions. Cardiol Therapeutics Inc. shares T.CRDL are trading up $0.18 at $3.20.